Relevance of the Type I Interferon Signature in Multiple Sclerosis Towards a Personalized Medicine Approach for Interferon-beta Therapy

C.L. Verweij, S. Vosslamber

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)51-60
JournalDiscovery Medicine
Volume80
Publication statusPublished - 2013

Cite this